CBD remains a controversial substance: The Food Drug and Cosmetics Act bars its use as a food additive, but FDA enforcement has been limited. Where are we now with federal law as it relates to CBD, is CBD derived from industrial hemp treated differently from isolate derived from psychoactive cannabis, and what is the best way to position your client for success? With the rise of the new hemp economy, the competitive landscape continues to tighten, and, now more than ever, our clients need guidance on how the market will develop and where resources should be allocated.
(This session is part of INCBA's three-day Cannabis Law Institute.)